This site is intended for healthcare professionals
News

Lilly's donanemab slows clinical decline of Alzheimer's disease in positive phase II trial.

Read time: 1 mins
Last updated:12th Jan 2021
Published:12th Jan 2021
Condition: Alzheimers
Type: drug
Register for free exclusive healthcare eLearning resources


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest